Goldman Sachs upgraded NuVasive (NASDAQ: NUVA) from Sell to Neutral with a price target of $36.00 (from $27.00), saying 4Q13 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE